LETROZOL SERVYCAL

LETROZOLE 2.5 mg

Coated Tablets

Sale under filed prescription Made in Argentina

QUALI-QUANTITATIVE COMPOSITION:
Each coated tablet contains:
Letrozole............................................................... 2.50 mg
Lactose monohydrate............................................ 60.00 mg
Sodium starch glycollate........................................ 3.00 mg
PVP K-30............................................................... 4.00 mg
Microcrystalline cellulose....................................... 23.00 mg
Magnesium stearate.............................................. 1.00 mg
Pregelatinized starch............................................. 10.00 mg
Hydroxypropyl methylcellulose.............................. 3.25 mg
Polyethylene glycol 6000....................................... 2.00 mg
Titanium dioxide.................................................... 0.75 mg

THERAPEUTIC ACTION
Antiestrogen.

INDICATIONS
Letrozole is indicated for the treatment of advanced breast cancer in women in the postmenopausal stage, whether natural or artificially induced, with disease progression or recurrence following antiestrogen therapy.

PRESENTATION
Carton containing 30 tablets.

Store at room temperature below 30º C and protected from light.